Hospitalization requiring intensive care unit due to SARS-CoV-2 infection correlated with IgM depression and IgG elevation

Aim: This study investigated the humoral response against SARS-CoV-2 in patients needing intensive care unit (ICU) care compared with those on general medicine wards. Materials & methods: The authors retrospectively reviewed 113 hospitalized patients with COVID-19. They assessed antibody respons...

詳細記述

書誌詳細
出版年:Future Science OA
主要な著者: Sara Tamizuddin, Jason Cham, Yasamin Ghiasi, Luis Borroto, Cindy Cao, Natalia Orendain, Michael M Quigley, Laura J Nicholson, Amitabh C Pandey
フォーマット: 論文
言語:英語
出版事項: Taylor & Francis Group 2022-03-01
主題:
オンライン・アクセス:https://www.future-science.com/doi/10.2144/fsoa-2021-0126
その他の書誌記述
要約:Aim: This study investigated the humoral response against SARS-CoV-2 in patients needing intensive care unit (ICU) care compared with those on general medicine wards. Materials & methods: The authors retrospectively reviewed 113 hospitalized patients with COVID-19. They assessed antibody response against five SARS-CoV-2 epitopes at 6–14 days post symptom onset in these patients. Results: Patients with ICU admissions had decreased anti-nucleocapsid immunoglobulin (Ig)M and increased anti-spike IgG compared with patients not requiring the ICU. IgG levels were positively correlated with length of stay. Conclusion: Higher levels of IgG against the spike protein correlate with COVID-19 disease severity and length of stay in hospitalized patients. This adds to the knowledge of biochemical response to clinical disease and may help predict ICU needs.
ISSN:2056-5623